Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.[1]
^Cite error: The named reference Baxdela FDA label was invoked but never defined (see the help page).
Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections...
clinafloxacin gatifloxacin moxifloxacin sitafloxacin prulifloxacin besifloxacin delafloxacin Two structurally related third-generation drugs, but formally not 4-quinolones...
combination (cell wall synthesis inhibitor). FDA approved on 29 August 2017. Delafloxacin: quinolone (inhibitor of DNA synthesis). FDA approved on 19 June 2017...
updated the public on eight new-generation fluoroquinolones: moxifloxacin, delafloxacin, ciprofloxacin, ciprofloxacin extended-release, gemifloxacin, levofloxacin...
pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin". Annals of Clinical Microbiology...